SOLESENCE, INC. — Director's Dealing 2007

Nov 1, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES CORPORATION (NANX)
CIK: 0000883107
Period of Report: 2007-10-30

Reporting Person: HAINES ROBERT W (VP - Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-10-30	Common Stock	F	442	$4.80	Disposed	2558	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2558	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$10.1875	2011-01-22	Common Stock (30000)	30000	Direct
Stock Option (right to buy)	$6.65	2012-01-03	Common Stock (40000)	40000	Direct
Stock Option (right to buy)	$3.66	2013-03-24	Common Stock (30000)	30000	Direct
Stock Option (right to buy)	$5.55	2014-10-11	Common Stock (11000)	11000	Direct
Stock Option (right to buy)	$5.84	2016-07-24	Common Stock (20000)	20000	Direct
Stock Option (right to buy)	$6.03	2015-09-27	Common Stock (10000)	10000	Direct
Stock Appreciation Right	$6.01	2016-09-27	Common Stock (15000)	15000	Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in five equal installments.

F2: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

F3: Subject to certain restrictions, beginning on this date, these stock appreciation rights vest in three equal annual installments.